These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk]. Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765 [No Abstract] [Full Text] [Related]
4. Clinical and Prognostic Value of Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959 [TBL] [Abstract][Full Text] [Related]
7. Performance of whole-body Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):847-855. PubMed ID: 30604061 [TBL] [Abstract][Full Text] [Related]
8. Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma. Gellén E; Sántha O; Janka E; Juhász I; Péter Z; Erdei I; Lukács R; Fedinecz N; Galuska L; Remenyik É; Emri G J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1938-44. PubMed ID: 25753249 [TBL] [Abstract][Full Text] [Related]
10. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence. Abbott RA; Acland KM; Harries M; O'Doherty M Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913 [TBL] [Abstract][Full Text] [Related]
11. 18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma. Wieder HA; Tekin G; Rosenbaum-Krumme S; Klode J; Altenbernd J; Bockisch A; Nagarajah J Nuklearmedizin; 2013; 52(5):198-203. PubMed ID: 23969722 [TBL] [Abstract][Full Text] [Related]
12. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538 [TBL] [Abstract][Full Text] [Related]
14. The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma. Stahlie EHA; van der Hiel B; Stokkel MPM; Schrage YM; van Houdt WJ; Wouters MW; van Akkooi ACJ J Surg Oncol; 2020 Dec; 122(7):1328-1336. PubMed ID: 32783266 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management. Mena E; Taghipour M; Sheikhbahaei S; Mirpour S; Xiao J; Subramaniam RM Clin Nucl Med; 2016 Sep; 41(9):e403-9. PubMed ID: 27355846 [TBL] [Abstract][Full Text] [Related]
16. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods. Dresel S; Grammerstorff J; Schwenzer K; Brinkbäumer K; Schmid R; Pfluger T; Hahn K Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):995-1003. PubMed ID: 12739070 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
18. S-100B as an extra selection tool for FDG PET/CT scanning in follow-up of AJCC stage III melanoma patients. Deckers EA; Wevers KP; Muller Kobold AC; Damude S; Vrielink OM; van Ginkel RJ; Been LB; van Leeuwen BL; Hoekstra HJ; Kruijff S J Surg Oncol; 2019 Nov; 120(6):1031-1037. PubMed ID: 31468535 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438 [TBL] [Abstract][Full Text] [Related]
20. Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma Koskivuo I; Kemppainen J; Giordano S; Seppänen M; Veräjänkorva E; Vihinen P; Minn H Acta Oncol; 2016 Nov; 55(11):1355-1359. PubMed ID: 27553064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]